Text Size: A- A+ Facebook Twitter LinkedIn YouTube

Breaking News



Format: 04/16/2014
Format: 04/16/2014


Pittsburgh Business Times: Value of Precision’s Test Show, featuring Dr. Thomas Krivak, gynecologic oncology

Thursday, July 11th, 2013

A cancer test developed in Pittsburgh is proving its value.

Dr. Thomas Krivak, director of clinical research in gynecologic oncology at West Penn Allegheny Health System, found that a test developed by Precision Therapeutics Inc. can show who will mostly likely not respond to platinum-based chemotherapy for ovarian cancer, a standard approach in treating the disease. More important, test results can be available before treatment begins.

To read more, visit the Pittsburgh Business Times website.

West Penn Allegheny Health System
Tell us who you are:

What areas do you use on our website?*
(select more than one if it applies)

Did you find what you were looking for?

Would you refer others to our website?

Can we contact you for future questions?

CAPTCHA math question:* 8 + 8 =

Thank you for completing the West Penn Allegheny Health System website survey.
We value your feedback and comments.